Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure

Stopped Today Entresto treatment has marketing authorization and is available for all patients, that is the reason why study was halted prematurely.

Conditions

• Heart Failure

Interventions

• DRUG: valsartan/sacubitril 100 mg
• DRUG: valsartan/sacubitril 200 mg
• PROCEDURE: Microneurography

Sponsor

University Hospital, Toulouse